Altogether, putatively tumor-reactive DP CD8+ T cells expressed higher levels of coinhibitory markers, had a higher proliferative capacity, and acquired a unique chemokine receptor expression profile by the upregulation of CCR5 and CXCR6 and downregulation of CXCR3 and CXCR4. The gene discussed is CCR5; the disease is neoplasm.